Covid-19 vaccine tracker, Sept 10: AstraZeneca trial paused after volunteer developed neurological symptoms
Coronavirus (COVID-19) vaccine tracker September 10 Update: The report also said that the trials had been halted once earlier as well, in July, after another participant had also developed neurological problems. The patient was later diagnosed with multiple sclerosis, something that was assessed to be unrelated to the vaccine.
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic
Coronavirus (COVID-19) Vaccine Tracker: The volunteer whose serious ailment halted clinical trials of a coronavirus vaccine candidate being developed by AstraZeneca and Oxford University is a woman who has shown symptoms of a neurological disorder that affects the spinal cord, according to a report in Stat News, the media organisation which first reported that the clinical trials had been paused.
The report said information about the woman was released by AstraZeneca CEO Pascal Soriot during a “private conference call” with company investors. It said the CEO had informed the investors that the woman had symptoms of a rare disease called transverse myelitis, but that her condition was improving and she was likely to be discharged from the hospital soon.